Want to contact a Zetia attorney in District of Columbia?...Get a free case evaluation from one of our Zetia attorneys in District of Columbia now.

Zetia - News Articles

Lurching Around For Fun and Profit. In the Pipeline:
May 21, 2008
Corante, MA -
There’s ezetimibe, discovered by sheer chance (but developed by sheer determination, though) and the thrombin receptor antagonist, squirrelly chemical ...
In Which I Hate A Wonder Drug. In the Pipeline:
May 13, 2008
Corante, MA -
Vytorin (ezetimibe) is the example I’ve spoken about here, and if the drug doesn’t seem like a savior at the moment, well, you have to keep in mind that it was the biggest thing for them since Claritin went off-patent ten years ago. Now there’s another one ...
Study Deals Setback to Cholesterol Drug - WSJ.com
Jan 14, 2008
Wall Street Journal -
The study -- known as Enhance, or Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients ...
Vytorin Results Disappointing, Experts Say Don't Panic
Jan 16, 2008
Medical News Today, UK -
ENHANCE stands for Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia. The ACC said the study deserves "serious thought and follow-up". The overall rate of ...
News - Statement from the American Heart Association on ENHANCE Study Results
Jan 16, 2008
DG News -
DALLAS, TX -- January 16, 2008 -- Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. ...
National Lipid Association Statement on ENHANCE Study Findings: Premature Judgment Unwarranted - Press Release
Jan 17, 2008
Earthtimes, UK -
JACKSONVILLE, Fla., Jan. 17 -- The limitations of the ENHANCE study, in terms of its design and the patients studied, are such that physicians should not alter their prescribing policies at this time. Current discussion regarding the ENHANCE Study is not based upon published work ...
ENHANCE results yield disappointment for ezetimibe
Jan 14, 2008
TheHeart.Org, NY -
At baseline, the mean carotid IMT measurement for the ezetimibe/simvastatin group was 0.68 mm and for the simvastatin-80-mg group was 0.69 mm. ...
ENHANCE saga continues: Experts dispute ezetimibe's future and "weight" of imaging studies
Jan 16, 2008
TheHeart.Org, NY -
It was the lead item on many US television news programs on Monday, and sales of ezetimibe—which have been running at around $5 billion worldwide—are now ...
Health 24 - News, The week in health
Thursday, January 17, 2008
Health24.com, South Africa -
Researchers reported this week that the widely prescribed cholesterol-lowering drug Ezetimibe (Zetia) does not confer any medical benefit. ...
Medical News: ENHANCE Finds No Slowing of Plaque Burden With Ezetimibe/Simvastatin (Vytorin) - in Cardiovascular, Dyslipidemia from MedPage Today
Jan 14, 2008
MedPage Today, NJ -
14 -- The combination of ezetimibe/simvastatin (Vytorin) did not appear to slow progression of atherosclerosis among patients with heterozygous familial hypercholesterolemia, doesn't that imply that genetically they are producing too much cholesterol ?If that is true, then it is ...
Medical News: AHA Calls for Major Effort to Increase CPR Training - in Cardiovascular, Arrhythmias from MedPage Today
Jan 16, 2008
MedPage Today, NJ -
By Peggy Peck, Executive Editor, MedPage Today DALLAS, Jan. 16 -- A shortage of people trained in CPR contributes to the approximately 150000 ...
Medical News: Heart Groups Call for Time Out In Ezetimibe/Simvastatin (Vytorin) Debate - in Cardiovascular, Dyslipidemia from MedPage Today
Jan 16, 2008
MedPage Today, NJ -
By Peggy Peck, Executive Editor, MedPage Today WASHINGTON, Jan. 16 -- Both the American College of Cardiology and the American Heart Association have warned against a rush to judgment on ezetimibe/simvastatin (Vytorin) on the basis of the scant details of the ENHANCE study ...
Adding Zetia to Zocor (Vytorin) Does Not Improve Atherosclerosis
Jan 15, 2008
About.com - Drugs, NY -
A new trial of 720 patients showed that adding Zetia (ezetimibe) to Zocor (simvastatin) provides no benefit for reducing atherosclerotic plaques. ...
13abc.com: New study on heart drug Zetia 1/15/08
Jan 15, 2008
13abc.com, OH -
About one million new presciptions for Zetia are written each week, and it is a big seller for Merck and Schering Plough, the drug companies which combine Zetia to make the drug Zocor. Now a new study raises questions about Zetia's effectiveness. ...
Zetia in Vytorin Does Not Stop Plaque Buildup; Better Off with Just Simivastatin
Jan 15, 2008
SeniorJournal.com, TX -
15, 2008 – The bottom line for cholesterol-fighting senior citizens is that Zetia does not work in reducing your heart disease risk. It does not reduce your risk of clogged arteries as a part of Vytorin, either. ...
phillyBurbs.com Blogs | Numbers don’t lie, Vytorin works
Jan 16, 2008
phillyBurbs.com, PA -
While I certainly don’t like the price - about $40-50 per month out of my own pocket in adddition to what insurance pays - it’s hard to argue that Vytorin isn’t effective. In just two months of being on a higher dosage of the stuff, after years ...
Cardiologist Comments on Zetia Issues - CBS 21
Jan 15, 2008
CBS 21, PA -
The word is out about the cholesterol reducing drug Zetia. A recent study shows it may not have the effectiveness that the medical community first thought. CBS 21 News spoke with a local cardiologist who says we're yet to hear the final word on the ...
phillyBurbs.com Blogs | Numbers don’t lie, Vytorin works
Jan 16, 2008
phillyBurbs.com, PA -
A lifelong Philly sports fan, I've been proudly breaking the Internet since 1999 when I first became an online editor. In my first life, I was an award-winning investigative reporter - a different kind of hired geek - for 12 years. ...
ABC News: Lipitor Pitchman Defends Role in Ad
Jan 16, 2008
ABC News -
A congressional subcommittee is investigating celebrity endorsements in direct-to-consumer drug ads, including Lipitor's ads featuring Robert Jarvik, inventor of the artificial heart. (ABC News Photo Illustration) ...
Profit at the heart of drug firms' reckless marketing | ajc.com
Jan 16, 2008
Atlanta Journal Constitution,  USA -
Twenty-five years ago, young Robert Jarvik was a physician-inventor best known for a plastic-and-titanium artificial heart that seemed to work for a while but had a nasty habit of causing strokes. Now he's the frontman for a multi-million-dollar advertising campaign for the ...
Want to contact a Zetia attorney in District of Columbia?...Get a free case evaluation from one of our Zetia attorneys in District of Columbia now.

Pages:   1   2   3   4   5   6   ...   Next

AddThis Social Bookmark Button

 

Need A Zetia Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Zetia Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Zetia Case - Submit Your Information Below

Do you need legal assistance with your Zetia case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Zetia Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.